Eupraxia Pharmaceuticals EPRX Income Statements

*Across 3 years £2132.64 only £853.06

Hot Features

Connect with traders and investors in our Follow Feed community.

Explore comprehensive options data and use advanced filters with Options Flow.

Organize and monitor your stock and asset watchlist with Monitor.

Premium

Year End 31 December 2023	2020	2021	2022	2023
	CAD ($)	CAD ($)	CAD ($)	USD (US$)
Total Revenue	0	0	0	0
Operating Income	-2.25M	-18.68M	-23.2M	-27.85M
Pre Tax Income	-4.01M	-23.37M	-23.92M	-28.93M
Net Income	-4.01M	-22.99M	-23.26M	-28.22M
Preferred Dividends	0	0	0	0
Basic Earnings Per Share (EPS)	-0.649	-1.614	-1.077	-1.034
EBIT	-2.12M	-22.21M	-23.21M	-28.68M
EBITDA	-2.13M	-18.57M	-23.01M	-27.85M